Skip to main content

What is the mechanism of action for Cimzia?

Medically reviewed by Kristianne Hannemann, PharmD. Last updated on June 27, 2024.

Official answer

by drugclasses.com

Cimzia (certolizumab pegol) is a tumor necrosis factor (TNF) blocker. TNF is a protein made by white blood cells that can cause inflammation in the body. Cimzia works by attaching to TNF-α and stops it from working to produce inflammatory substances such as interleukin-1 (IL-1), nitric oxide, and prostaglandins.

Research shows that TNF is involved in many inflammatory conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. By neutralizing TNF, inflammation in the body is reduced. This results in an improvement of symptoms for a variety of autoimmune conditions.

Cimzia is PEGylated, which means it is attached to polyethylene glycol. This helps the medication stay in your body longer before it is broken down.

Is Cimzia a TNF antagonist?

Yes. Cimzia is a TNF antagonist, also sometimes called a TNF blocker. It attaches to and neutralizes TNF-α, which is a substance that causes inflammation in the body. By blocking the actions of TNF, patients with various inflammatory conditions experience relief of their symptoms.

What is Cimzia used for?

Cimzia is an anti-TNF biologic that is FDA approved to treat the following conditions:

  • Crohn’s disease
  • Rheumatoid arthritis
  • Psoriatic arthritis
  • Ankylosing spondylitis
  • Non-radiographic axial spondyloarthritis
  • Psoriasis

Cimzia has not been studied well in children, and it is currently only approved for adults. It’s given as an injection under the skin every 2 to 4 weeks.

References

Goel, N., et. al. (2010). Certolizumab pegol. In: mAbs. DOI: https://doi.org/10.4161%2Fmabs.2.2.11271

National Cancer Institute. (n.d.). Tumor Necrosis Factor. Accessed 06/27/2024 at https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-necrosis-factor

Patel, A. M., et. al. (2014). Certolizumab pegol: a new biologic targeting rheumatoid arthritis. In: Expert Review of Clinical Pharmacology. DOI: https://doi.org/10.1586%2Feci.10.69

Read next

What does psoriasis look like?

Psoriasis typically appears as a red, dry, and flaky patch of skin, and may be covered with white scales called plaques. It can occur on any area of the body, including hands, feet, elbows, scalp or genitals. Psoriasis can feel itchy, sore, burning and the skin may feel tight, crack or bleed. Frequent itching can lead to thicker areas of plaques. Continue reading

How does Ilumya work to treat psoriasis?

Ilumya works by binding selectively to interleukin-23 (IL-23) which is a naturally occurring cytokine. IL-23 plays a key role in promoting inflammation and regulating other cytokines (such as IL-17) and inflammatory substances, such as TNF-α3-7. By blocking the effects of IL-23, Ilumya helps control the release of IL-17 and TNF-α, which reduces inflammation associated with psoriasis. It also decreases how many inflammatory cells are present within psoriatic lesions, helps prevent plaque formation, and resolves tissue damage. Continue reading

Prednisone: What are 12 Things You Should Know?

Prednisone first came onto the market over sixty years ago and is still going strong. But did you know that this common drug used for a variety of different conditions also has some pretty serious side effects as well? Continue reading

Related medical questions

Drug information

Related support groups